VERACYTE, INC.（VCYT）内部人交易：高管与董事近期交易
过去 18 个月，共有 15 位内部人为 VERACYTE, INC.（VCYT）报告了 148 笔 Form 4 交易（最近一笔 2026-09-22）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-22 | Leite John | Global Chief Commercial Off | 卖出 | 4,015 | $160,600 |
| 2026-09-16 | Holstein Jens | 董事 | 卖出 | 5,000 | $204,747 |
| 2026-09-04 | Chambers Rebecca | Chief Financial Officer | 卖出 | 1,175 | $51,364 |
| 2026-09-04 | Wygant Jonathan | VP, Chief Accounting Officer | 卖出 | 1,361 | $61,082 |
| 2026-09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | 卖出 | 3,639 | $163,318 |
| 2026-09-04 | Chambers Rebecca | Chief Financial Officer | 卖出 | 3,603 | $161,703 |
| 2026-09-04 | McGuire Annie | EVP, General Counsel | 卖出 | 3,215 | $144,289 |
| 2026-09-04 | Leite John | Global Chief Commercial Off | 卖出 | 3,961 | $177,770 |
| 2026-09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | 卖出 | 10,405 | $446,305 |
| 2026-09-04 | Chambers Rebecca | Chief Financial Officer | 卖出 | 2,477 | $106,030 |
| 2026-09-04 | McGuire Annie | EVP, General Counsel | 卖出 | 2,154 | $92,173 |
| 2026-09-04 | Febbo Phillip G. | Chief Scientific & Med Officer | 卖出 | 2,705 | $118,105 |
| 2026-09-04 | Stapley Marc | Chief Executive Officer | 卖出 | 8,782 | $394,136 |
| 2026-09-04 | McGuire Annie | EVP, General Counsel | 卖出 | 1,100 | $48,039 |
| 2026-09-03 | Bhanji Muna | 董事 | 卖出 | 1,864 | $80,096 |
| 2026-06-22 | EASTHAM KARIN | 董事 | 卖出 | 3,200 | $168,896 |
| 2026-06-22 | EASTHAM KARIN | 董事 | 卖出 | 529 | $28,328 |
| 2026-06-15 | Bhanji Muna | 董事 | 买入 | 5,272 | $0 |
| 2026-06-15 | Barr Eliav | 董事 | 买入 | 5,272 | $0 |
| 2026-06-15 | Miller Thomas F. | 董事 | 买入 | 5,272 | $0 |
| 2026-06-15 | EASTHAM KARIN | 董事 | 买入 | 5,272 | $0 |
| 2026-06-15 | Holstein Jens | 董事 | 买入 | 5,272 | $0 |
| 2026-06-15 | Shafer David Brent | 董事 | 买入 | 5,272 | $0 |
| 2026-06-15 | EPSTEIN ROBERT S | 董事 | 买入 | 5,272 | $0 |
| 2026-06-15 | JONES EVAN/ FA | 董事 | 买入 | 5,272 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22